To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer
NCT04514289 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 106
Last updated 2020-08-14
Summary
to assess and compare the performance two approaches for sentinel lymph node ( SLND) biopsy
Conditions
- Endometrial Cancer
- Sentinel Lymph Node
- Indocyanine Green
Interventions
- DRUG
-
Indocyanine green solution
Indocyanine green (ICG) is a cyanine dye used in medical diagnostics.ICG is a fluorescent dye that is used in medicine as an indicator substance.
Sponsors & Collaborators
-
Haseki Training and Research Hospital
lead OTHER
Principal Investigators
-
Cihan Comba, M.D. · Sultangazi Haseki Training and Research Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2021-06-30
- Completion
- 2021-08-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Sentinel Lymph Node (SLN) Mapping with Charcoal Carbon Dye in Early Stage Cervical Cancer
NCT06697054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
NCT03900104 ·Status: COMPLETED ·Phase: NA
-
Lymph Node Mapping in Patients With Endometrial Cancer
NCT01818739 ·Status: COMPLETED ·Phase: NA
-
Sentinel Node in Endometrial Cancer
NCT04492995 ·Status: UNKNOWN ·Phase: PHASE2
-
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
NCT00070317 ·Status: TERMINATED ·Phase: NA
-
Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue
NCT07040657 ·Status: RECRUITING ·Phase: NA
-
Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
NCT01673022 ·Status: COMPLETED ·Phase: NA
-
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
NCT05646316 ·Status: RECRUITING ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer
NCT05048173 ·Status: COMPLETED
-
Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer
NCT04246580 ·Status: COMPLETED
-
Sentinel Lymph Node Detection in Early Cervical Cancer
NCT02543775 ·Status: COMPLETED ·Phase: NA
-
Sentinel Node and Endometrial Cancer
NCT00987051 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer
NCT04577950 ·Status: UNKNOWN ·Phase: NA
-
Improved Method of Detecting Cancer Metastases
NCT02368067 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Mapping In Cervical Cancer
NCT03778268 ·Status: UNKNOWN ·Phase: NA
-
Strain-elastography in Endometrial Cancer
NCT06623916 ·Status: COMPLETED
-
Sentinel Node Mapping in Women With Endometrial and Cervical Cancer
NCT02820506 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Carbon Nanoparticles and Indocyanine Green for Sentinel Lymph Node Biopsy in Early Stage Cervical Cancer
NCT05167149 ·Status: UNKNOWN ·Phase: NA
-
Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer
NCT04663412 ·Status: UNKNOWN ·Phase: NA
-
Use of the Sentinel Node Biopsy for Early Endometrial Cancer.
NCT02545348 ·Status: UNKNOWN
-
Gynecological Sentinel Lymph Nodes CEUS
NCT05105087 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers
NCT00773071 ·Status: COMPLETED ·Phase: NA
-
TMTP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer
NCT03321448 ·Status: UNKNOWN ·Phase: PHASE1
-
Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma
NCT02988765 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Nodes Biopsy in Cervical Cancer
NCT06169787 ·Status: ACTIVE_NOT_RECRUITING